Caveolar uptake and endothelial-protective effects of nanostructured lipid carriers in acid aspiration murine acute lung injury

Pharmaceutical Research

Volumn 30, Issue 7, 2013, Pages 1836-1847

  Kardara, Matina ^a   Hatziantoniou, Sophia ^b   Sfika, Aggeliki ^a   Vassiliou, Aliki G ^a   Mourelatou, Elena ^b   Magkou, Christina ^c   Armaganidis, Apostolos ^a   Roussos, Charalambos ^a   Orfanos, Stylianos E ^a   Kotanidou, Anastasia ^a   Maniatis, Nikolaos A ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c EVANGELISMOS HOSPITAL   (Greece)

Author keywords

acute lung injury; extracellular regulated kinase; nanomedicine; permeability; thrombin

Indexed keywords

ALBUMIN; CAVEOLIN 1; COAT PROTEIN; CURCUMIN; HYDROCHLORIC ACID; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; NANOPARTICLE; NANOSTRUCTURED LIPID CARRIER; PROTEIN P42; PROTEIN P44; SODIUM CHLORIDE; THROMBIN; UNCLASSIFIED DRUG;

ACID ASPIRATION; ACTIN FILAMENT; ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAVEOLA; CELL FREE SYSTEM; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG MECHANISM; DRUG STABILITY; EMULSION; ENDOSOME; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; HUMAN CELL; INFLAMMATORY CELL; MALE; MICROVASCULAR ENDOTHELIAL CELL; MOUSE; NEUTROPHIL; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SCORING SYSTEM; SIGNAL TRANSDUCTION; SINGLE DRUG DOSE;

ACUTE LUNG INJURY; ANIMALS; BLOOD COAGULATION; CAVEOLAE; CAVEOLIN 1; CELL LINE; CYTOKINES; ENDOTHELIAL CELLS; HUMANS; LUNG; MALE; MICE; MICE, INBRED C57BL; NANOSTRUCTURES; PERMEABILITY; PHOSPHOLIPIDS; THROMBIN; TRIGLYCERIDES;

EID: 84878819291     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-013-1027-2     Document Type: Article

References (28)

1. Donahoe M. Acute respiratory distress syndrome: a clinical review. Pulm Circ. 2011;1:192-211.
2. Kolhe P, Misra E, Kannan RM, Kannan S, Lieh-Lai M. Drug complexation, in vitro release and cellular entry of dendrimers and hyperbranched polymers. Int J Pharm. 2003;259:143-60. (Pubitemid 36638561)
3. Langer R. Drug delivery and targeting. Nature. 1998;392:5-10. (Pubitemid 28215187)
4. Yang XY, Li YX, Li M, Zhang L, Feng LX, Zhang N. Hyaluronic acid-coated nanostructured lipid carriers for targeting paclitaxel to cancer. Cancer Lett. 2012, Jul 7 [Epub ahead of print].
5. Liu R, Liu Z, Zhang C, Zhang B. Nanostructured lipid carriers as novel delivery system for mangiferin: improving in vivo ocular bioavailability. J Pharm Sci. 2012;101:3833-44.
6. Alam MI, Baboota S, Ahuja A, Ali M, Ali J, Sahni JK. Intranasal administration of nanostructured lipid carriers containing CNS acting drug: pharmacodynamic studies and estimation in blood and brain. J Psychiatr Res. 2012;46:1133-8.
7. Zhen G, Hinton TM, Muir BW, Shi S, Tizard M, McLean KM, et al. Glycerol monooleate based nanocarriers for siRNA delivery in vitro. Mol Pharm. 2012. Jul 16 [Epub ahead of print].
8. Haque S, Md S, Alam MI, Sahni JK, Ali J, Baboota S. Nanostructure-based drug delivery systems for brain targeting. Drug Dev Ind Pharm. 2012;38:387-411.
9. Angelova A, Angelov B, Mutafchieva R, Lesieur S, Couvreur P. Self-assembled multicompartment liquid crystalline lipid carriers for protein, peptide, and nucleic acid drug delivery. Acc Chem Res. 2011;44:47-56.
10. Das S, Chaudhury A. Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery. AAPS PharmSciTech. 2011;12:62-76.
11. Joshi MD, Muller RH. Lipid nanoparticles for parenteral delivery of actives. Eur J Pharm Biopharm. 2009;71:161-72.
12. Garcia-Fuentes M, Alonso MJ, Torres D. Design and characterization of a new drug nanocarrier made from solid-liquid lipid mixtures. J Colloid Interface Sci. 2005;285:590-8. (Pubitemid 40544678)
13. Deli G, Hatziantoniou S, Nikas Y, Demetzos C. Solid lipid nanoparticles and nanoemulsions containing ceramides: preparation and physicochemical characterization. J Liposome Res. 2009;19:180-8.
14. Hatziantoniou S, Deli G, Nikas Y, Demetzos C, Papaioannou GT. Scanning electron microscopy study on nanoemulsions and solid lipid nanoparticles containing high amounts of ceramides. Micron. 2007;38:819-23. (Pubitemid 47554621)
15. Hatziantoniou S, Demetzos C. Qualitative and quantitative one-step analysis of lipids and encapsulated bioactive molecules in liposome preparations by HPTLC/FID (IATROSCAN). J Liposome Res. 2006;16:321-30. (Pubitemid 44949883)
16. Hatziantoniou S, Demetzos C. Method of simultaneous analysis of liposome components using HPTLC/FID. Methods Mol Biol. 2010;606:363-8.
17. Kotanidou A, Loutrari H, Papadomichelakis E, Glynos C, Magkou C, Armaganidis A, et al. Inhaled activated protein C attenuates lung injury induced by aerosolized endotoxin in mice. Vasc Pharmacol. 2006;45:134-40. (Pubitemid 44374413)
18. Krump-Konvalinkova V, Bittinger F, Unger RE, Peters K, Lehr HA, Kirkpatrick CJ. Generation of human pulmonary microvascular endothelial cell lines. Lab Invest. 2001;81:1717-27. (Pubitemid 33144434)
19. Psallidas I, Stathopoulos GT, Maniatis NA, Magkouta S, Moschos C, Karabela SP, et al. Secreted phosphoprotein-1 directly provokes vascular leakage to foster malignant pleural effusion. Oncogene. 2012. February. [Epub ahead of print].
20. Marik PE. Aspiration syndromes: aspiration pneumonia and pneumonitis. Hosp Pract (Minneap). 2012;38:35-42.
21. Matute-Bello G, Frevert CW, Martin TR. Animal models of acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2008;295:L379-99.
22. Wang Z, Tiruppathi C, Cho J, Minshall RD, Malik AB. Delivery of nanoparticle: complexed drugs across the vascular endothelial barrier via caveolae. IUBMB Life. 2011;63:659-67.
23. Oh P, Borgstrom P, Witkiewicz H, Li Y, Borgstrom BJ, Chrastina A, et al. Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung. Nat Biotechnol. 2007;25:327-37. (Pubitemid 46398772)
24. Cohen AW, Hnasko R, Schubert W, Lisanti MP. Role of caveolae and caveolins in health and disease. Physiol Rev. 2004;84(4):1341-79. (Pubitemid 39287953)
25. Suchner U, Katz DP, Furst P, Beck K, Felbinger TW, Senftleben U, et al. Effects of intravenous fat emulsions on lung function in patients with acute respiratory distress syndrome or sepsis. Crit Care Med. 2001;29:1569-74. (Pubitemid 32762338)
26. Kalimeris K, Christodoulaki K, Karakitsos P, Batistatou A, Lekka M, Bai M, et al. Influence of propofol and volatile anaesthetics on the inflammatory response in the ventilated lung. Acta Anaesthesiol Scand. 2011;55:740-8.
27. Ypsilantis P, Politou M, Mikroulis D, Pitiakoudis M, Lambropoulou M, Tsigalou C, et al. Organ toxicity and mortality in propofol-sedated rabbits under prolonged mechanical ventilation. Anesth Analg. 2007;105:155-66. (Pubitemid 46975862)
28. Ott J, Hiesgen C, Mayer K. Lipids in critical care medicine. Prostaglandins Leukot Essent Fat Acids. 2011;85:267-73.